Literature DB >> 16413335

Gyrus bipolar versus standard monopolar transurethral resection of the prostate: a randomized prospective trial.

Marco de Sio1, Riccardo Autorino, Giuseppe Quarto, Rocco Damiano, Sisto Perdonà, Giuseppe di Lorenzo, Salvatore Mordente, Massimo D'Armiento.   

Abstract

OBJECTIVES: To compare bipolar plasmakinetic (PK) with standard monopolar transurethral resection of the prostate (TURP).
METHODS: A total of 70 patients were prospectively randomized into two groups: 35 patients underwent PK TURP with the Gyrus device, and 35 patients underwent standard monopolar TURP. We evaluated the time to catheter removal and hospital discharge, operating time, blood loss, postoperative irrigation, complications, urinary flow rates, symptom relief, and postvoid residual volumes.
RESULTS: At baseline, the study groups were comparable in age, prostate volume, mean prostate-specific antigen value, International Prostate Symptom Score, quality-of-life score, flow rate, and postvoid residual volume. The mean catheterization time was 72 and 100 hours in the PK and standard groups, respectively. This difference was statistically significant (P <0.05), as was the difference in the time to hospital discharge. No difference was found in the mean resection time, amount of resected tissue, or variations in hemoglobin and sodium levels. The improvement in flow rate, postvoid residual volume, International Prostate Symptom Score, and quality-of-life score was comparable between the two groups at 12 months of follow-up.
CONCLUSIONS: In our experience, PK TURP showed comparable perioperative results to those obtained with standard TURP, but with more favorable postoperative outcomes. The resection time and blood loss were similar between the two groups, but the need for continuous bladder irrigation after surgery and time to catheter removal and hospital discharge were significantly shorter in the PK group.

Entities:  

Mesh:

Year:  2006        PMID: 16413335     DOI: 10.1016/j.urology.2005.07.033

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  29 in total

1.  [Benign prostate hyperplasia].

Authors:  U Jonas; A I Gabouev; T R W Herrmann; K Höfner; M C Michel; M Alschibaja; R Hartung
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

2.  A prospective study comparing bipolar endoscopic enucleation of prostate with bipolar transurethral resection in saline for management of symptomatic benign prostate enlargement larger than 70 g in a matched cohort.

Authors:  Chi Fai Kan; Hok Leung Tsu; Yi Chiu; Hoi Chu To; Bonnie Sze; Steve Wai Hee Chan
Journal:  Int Urol Nephrol       Date:  2013-09-08       Impact factor: 2.370

3.  HoLEP provides a higher prostate cancer detection rate compared to bipolar TURP: a matched-pair analysis.

Authors:  Bernd Rosenhammer; Eva M Lausenmeyer; Roman Mayr; Maximilian Burger; Christian Eichelberg
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

4.  [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-12       Impact factor: 0.639

Review 5.  Bipolar transurethral resection versus monopolar transurethral resection for benign prostatic hypertrophy: a systematic review and meta-analysis.

Authors:  Yin Tang; Jinhong Li; Chuanxiao Pu; YunJin Bai; HaiChao Yuan; Qiang Wei; Ping Han
Journal:  J Endourol       Date:  2014-06-05       Impact factor: 2.942

6.  Prospective randomized study comparing monopolar with bipolar transurethral resection of prostate in benign prostatic obstruction: 36-month outcomes.

Authors:  Samer Fathi Al-Rawashdah; Antonio Luigi Pastore; Yazan Al Salhi; Andrea Fuschi; Vincenzo Petrozza; Angela Maurizi; Ester Illiano; Elisabetta Costantini; Giovanni Palleschi; Antonio Carbone
Journal:  World J Urol       Date:  2017-02-27       Impact factor: 4.226

Review 7.  Thulium (Tm:YAG) laser vaporesection of prostate and bipolar transurethral resection of prostate in patients with benign prostate hyperplasia: a systematic review and meta-analysis.

Authors:  Yu Lan; Wenqi Wu; Luhao Liu; Shiyu Zhou; Chuangxin Lan; Irene Raphael Ketegwe; Guohua Zeng
Journal:  Lasers Med Sci       Date:  2018-06-27       Impact factor: 3.161

8.  [Benign prostatic syndrome (BPS). Ablative treatments].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; A Bachmann; C Stief
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

9.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

10.  A prospective, randomized clinical trial comparing bipolar plasma kinetic resection of the prostate versus conventional monopolar transurethral resection of the prostate in the treatment of benign prostatic hyperplasia.

Authors:  Christopher Ho Chee Kong; M Fadzli Ibrahim; Zulkifli Md Zainuddin
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.